Your browser doesn't support javascript.
loading
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML.
van der Lee, Dyantha I; Koutsoumpli, Georgia; Reijmers, Rogier M; Honders, M Willy; de Jong, Rob C M; Remst, Dennis F G; Wachsmann, Tassilo L A; Hagedoorn, Renate S; Franken, Kees L M C; Kester, Michel G D; Harber, Karl J; Roelofsen, Lisanne M; Schouten, Annemiek M; Mulder, Arend; Drijfhout, Jan W; Veelken, Hendrik; van Veelen, Peter A; Heemskerk, Mirjam H M; Falkenburg, J H Frederik; Griffioen, Marieke.
Afiliación
  • van der Lee DI; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Koutsoumpli G; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Reijmers RM; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Honders MW; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • de Jong RCM; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Remst DFG; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Wachsmann TLA; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Hagedoorn RS; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Franken KLMC; Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Kester MGD; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Harber KJ; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Roelofsen LM; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Schouten AM; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Mulder A; Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Drijfhout JW; Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Veelken H; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • van Veelen PA; Center for Proteomics and Metabolomics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Heemskerk MHM; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Falkenburg JHF; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Griffioen M; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Cancers (Basel) ; 13(21)2021 10 27.
Article en En | MEDLINE | ID: mdl-34771556
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza